Explore All Access
Check if your research matches the topics covered in The Lancet HIV?
- Degree of match
- Common matching concepts
- Additional journal recommendations
The Lancet HIV : Impact Factor & More
eISSN: 2352-3018pISSN: 2352-3018
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
The Lancet HIV Key Metrics
CiteScore 
16
Scite Index
0.85 5-Year SI
SNIP
3.56
Time to Accept
3
Mo
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months40%
4 to 6 months20%
7 to 9 months25%
Above 9 months15%
Did you find this useful?
Topics Covered on The Lancet HIV
Cohort study
Viral load
Public health
Assay
Substance abuse
Randomized controlled trial
Misinformation
Opioid use
Burden of disease
Lamivudine
Placebo
Health professionals
Drug resistance
Seroconversion
Transgender
Systematic review
Interrupted time series
Median time
Observational study
Opioid use disorder
The Lancet HIV Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in The Lancet HIV ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in The Lancet HIV
Improving quality of interpersonal care in HIV programmes.
- 5 Dec 2024
- The lancet. HIV
Effect of a multicomponent, person-centred care intervention on client experience and HIV treatment outcomes in Zambia: a stepped-wedge, cluster-randomised trial.
- 5 Dec 2024
- The lancet. HIV
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
- 1 Dec 2024
- The Lancet HIV
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.
- 1 Dec 2024
- The lancet. HIV
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort study
- 1 Dec 2024
- The Lancet HIV
Correction to Lancet HIV 2024; 11: e783–90
- 1 Dec 2024
- The Lancet HIV
Improving quality of interpersonal care in HIV programmes.
- 5 Dec 2024
- The lancet. HIV
Effect of a multicomponent, person-centred care intervention on client experience and HIV treatment outcomes in Zambia: a stepped-wedge, cluster-randomised trial.
- 5 Dec 2024
- The lancet. HIV
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
- 1 Dec 2024
- The Lancet HIV
Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021.
- 1 Dec 2024
- The lancet. HIV
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort study
- 1 Dec 2024
- The Lancet HIV
Correction to Lancet HIV 2024; 11: e783–90
- 1 Dec 2024
- The Lancet HIV
Compare Similar Journals with The Lancet HIV
Select Journals to Compare with The Lancet HIV
Total journals - 9
You can select up to 3 Journals at a time
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
AIDS
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Journal of the International AIDS Society
Publisher: JOHN WILEY & SONS LTD
AIDS and Behavior
Publisher: SPRINGER/PLENUM PUBLISHERS
Open Forum Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
BMC Public Health
Publisher: BMC
BMJ Open
Publisher: BMJ PUBLISHING GROUP
Clinical Infectious Diseases
Publisher: OXFORD UNIV PRESS INC
AIDS Research and Human Retroviruses
Publisher: MARY ANN LIEBERT, INC
0 Journals Selected to compare with
The Lancet HIV
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on The Lancet HIV
How long has The Lancet HIV been actively publishing? 
The Lancet HIV has been in operation since 2014 till date.
What is the publishing frequency of The Lancet HIV?
The Lancet HIV published with a Monthly frequency.
How many articles did The Lancet HIV publish last year?
In 2023, The Lancet HIV publsihed 171 articles.
What is the eISSN & pISSN for The Lancet HIV?
For The Lancet HIV, eISSN is 2352-3018 and pISSN is 2352-3018.
What is Citescore for The Lancet HIV?
Citescore for The Lancet HIV is 16.
What is SNIP score for The Lancet HIV?
SNIP score for The Lancet HIV is 3.56.
Who is the publisher of The Lancet HIV?
ELSEVIER INC is the publisher of The Lancet HIV.
